OBESITY, ABDOMINAL
Clinical trials for OBESITY, ABDOMINAL explained in plain language.
Never miss a new study
Get alerted when new OBESITY, ABDOMINAL trials appear
Sign up with your email to follow new studies for OBESITY, ABDOMINAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Hormone drug trial aims to shrink dangerous liver fat
Disease control CompletedThis study tested whether a drug called tesamorelin could reduce liver fat and improve liver health in adults with obesity and nonalcoholic fatty liver disease (NAFLD). Researchers enrolled 51 participants to receive either tesamorelin or a placebo. The goal was to see if boostin…
Matched conditions: OBESITY, ABDOMINAL
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Can banning soda at work shrink your waistline?
Prevention CompletedThis study tested whether a two-part workplace program could help employees improve their health. Researchers examined if banning sugary drink sales at work and offering brief personal counseling could help reduce belly fat and improve the body's response to sugar. Over 600 hospi…
Matched conditions: OBESITY, ABDOMINAL
Phase: NA • Sponsor: University of California, San Francisco • Aim: Prevention
Last updated Mar 12, 2026 13:50 UTC